Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Anti-Adhesive Nanopatches Prevent Biofilm Formation

By HospiMedica International staff writers
Posted on 02 May 2016
A novel nano-coating could offer a significant advantage in battling biofilms for a variety of medical and industrial applications.

Developed by researchers at Ben-Gurion University (BGU; Beer Sheva, Israel), the anti-adhesive patches are based on the natural properties of microalgal-derived polysaccharides, and the significant anti-biofilm activity of a metal complex film (MCF) joined to copper (Cu) ions that improve the chemical, physical, and biological properties of the surfaces. More...
A mechanistic examination showed a two-fold greater coverage of the anti-adhesive surface of Cu-MCF due to the induction of a swarming motility, which impedes bacterial transformation to an irreversibly attached state.

They then examined the surface topography of the patches, using X-ray photoelectron spectroscopy (XPS) and Fourier transform infrared (FTIR) spectrometry. They found that the Cu-MCF patch surface morphology is comprised of protruding, needle-like structures up to 100 nm in height that lack both polysaccharides and a Zinc-MCF. The researchers concluded that patches fabricated with thermal and pressure stability--to prevent metal ion leakage--could hold promise for a broad spectrum of uses. The study was published on March 17, 2016, in Advanced Materials Interfaces.

“Our solution addresses a pervasive need to design environmentally friendly materials to impede dangerous surface bacteria growth,” concluded senior author Professor Ariel Kushmaro, PhD, and colleagues of the BGU departments of microbiology and biotechnology engineering. “Anti-adhesive patches that are developed from naturally occurring biomaterials can prevent destructive bacterial biofilm from forming on metal surfaces when they are immersed in water and other damp environments.”

“This holds tremendous potential for averting biofilm formed by surface-anchored bacteria and could have a tremendous impact,” concluded the authors. “The anti-adhesive could be used on medical implants, devices, and surgical equipment where bacteria can contribute to chronic diseases, resist antibiotic treatment and thereby compromise the body's defense system. The prevention of aquatic biofouling on ships and bridges is one of the industrial applications.”

Biomaterial infections are responsible for high rates of patient mortality and morbidity. The presence of biofilm bacteria, which thrive on implant surfaces, are a huge burden on healthcare budgets, as they are highly resistant to current therapeutic strategies.

Related Links:
Ben-Gurion University


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.